Stopped
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy · Locally Advanced Rectal Cancer
Trial terminated
Also in this update: Final enrollment: 215 participants (planned 550); Primary completion date changed from estimate of Aug 2030 to Jul 31, 2026
Ralf HofheinzPhase 3 NCT04495088 Registry history of NCT04495088 on ClinicalTrials.gov (opens the registry)